JorgeACarrasquilloMD
Nuclear Medicine • New York, NYPer Diem Consultant, Molecular Imaging and Therapy Service, Dpt. Radiology, Memorial Sloan Kettering Cancer Center,NY NY
Dr. Carrasquillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 646-227-3275
Education & Training
University of WashingtonResidency, Nuclear Medicine, 1981 - 1983
University of Puerto RicoResidency, Internal Medicine, 1974 - 1977- University of Puerto Rico School of MedicineClass of 1974
Certifications & Licensure
MD State Medical License 2002 - 2026
NY State Medical License 2006 - 2026
NJ State Medical License 2008 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2008-2014
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer Start of enrollment: 2007 Jan 01
- Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab Start of enrollment: 2006 Oct 01
- A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsManagement of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.David Taïeb, Svenja Nölting, Nancy D Perrier, Martin Fassnacht, Jorge A Carrasquillo
Nature Reviews. Endocrinology. 2024-03-01 - 4 citationsQuantitative PET imaging of the CD4 pool in nonhuman primates.Insook Kim, Sharat Srinivasula, Paula DeGrange, Brad Long, Hyukjin Jang
European Journal of Nuclear Medicine and Molecular Imaging. 2022-12-01 - 21 citationsPhase 1 study of intraventricularI-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.Kim Kramer, Neeta Pandit-Taskar, Brian H Kushner, Pat Zanzonico, John L Humm
Journal of Hematology & Oncology. 2022-11-12
Grant Support
- Radiolabeled Monoclonal Antibody Imaging Of Tumors And PClinical Center2002–2006
- Monoclonal Antibody Imaging Of Tumors And Positron EmmisClinical Center2005
- Radiolabeled Monoclonal Antibody Imaging Of Tumors &PetClinical Center2003
- Radiolabeled Monoclonal Antibody Imaging Of Tumors And PClinical Center2001
- Radiolabeled Monoclonal Antibody Imaging Of Tumors And Positron Emission TomograClinical Center2000
- Chemical Modifications Of Antibodies For Tumor TargetingClinical Center2000
- Radiolabeled Monoclonal Antibody Imaging Of Tumors And Positron Emission TomograpClinical Center1998–1999
- Improved Tumor Targeting Of Tc-99m FAB By Chemical ModificationsClinical Center1998–1999
- Radiolabeled Monoclonal Antibody Imaging Of TumorsClinical Center1997
- Evaluation Of TC 99m MAG3 Biocytin As Hepatobiliary AgentClinical Center1997
- Enhancement Of Renal Clearance Of TC 99m Dsfv By Chemical ModificationsClinical Center1997
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
